Buscador de publicacions

Publicacions

  • Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny-Guasch C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM and Ford D.

    Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

    LANCET CHILD & ADOLESCENT HEALTH . 7(10): 718-727. Nº de cites: 4

    [doi:10.1016/S2352-4642(23)00164-5]

  • Baquero-Artigao, F, del Rosal, T, Falcón-Neyra, L, Ferreras-Antolín, L, Gómez-Pastrana, D, Hernanz-Lobo, A, Méndez-Echevarría, A, Noguera-Julian A, Sánchez, MTP, Rodríguez-Molino, P, Piñeiro-Pérez, R, Santiago-García, B and Soriano-Arandes, A.

    Update on the diagnosis and treatment of tuberculosis

    ANALES DE PEDIATRIA . 98(6): 460-469. Nº de cites: 12

    [doi:10.1016/j.anpedi.2023.03.011]

  • Buonsenso D, Noguera-Julian A, Moroni R, Hernández-Bartolomé A, Fritschi N, Lancella L, Cursi L, Soler-García a, Krüger R, Feiterna-Sperling C, Sali M, Lo Vecchio A, Scarano S, Hernanz Lobo A, Espiau M, Soriano-Arandes A, Cetin BS, Brinkmann F, Ozere I, Baquero-Artigao F, Tsolia M, Milheiro Silva T, Bustillo-Alonso M, Martín Nalda A, Mancini M, Starshinova A, Ritz N, Velizarova S, Ferreras-Antolín L, Götzinger F, Bilogortseva O, Chechenyeva V, Tebruegge M and Santiago-García B.

    Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study

    Thorax . 78(3): 288-296. Nº de cites: 19

    [doi:10.1136/thorax-2022-218929]

  • López-Ramos MG, Vinent-Genestar J, Aarnoutse R, Colbers A, Velasco E, Martorell-Sampol L, Falcón-Neyra L, Neth O, Prieto L, Guillén S, Baquero-Artigao F, Méndez-Echevarría A, Gómez-Pastrana D, Jiménez AB, Lahoz R, Ramos-Amador JT, Soriano-Arandes A, Santiago B, Rosa Farré Riba, Fortuny-Guasch C, Soy D and Noguera-Julian A.

    Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

    ANTIBIOTICS-BASEL . 12(2): .

    [doi:10.3390/antibiotics12020272]

  • Calzada-Hernández J, Anton-Lopez J, Martín-de-Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.

    Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-a inhibitor initiation in children in Spain

    EUROPEAN JOURNAL OF PEDIATRICS . 182(1): 307-317. Nº de cites: 12

    [doi:10.1007/s00431-022-04640-3]

  • Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño MA, García Del Toro M, Hita C, Gómez-Sirvent JL, Buzón L, Díaz de Santiago A, Pérez Arellano JL, Sanz J, Bachiller P, Martínez Alfaro E, Diaz de Brito V, Masiá M, Hernández-Torres A, Guerra J, Santos J, Arazo P, Muñoz L, Arribas JR, Martínez de Salazar P, Moreno S, Hernán MA, Del Amo J, Del Amo J, Rosa Polo, Moreno S, Berenguer J, Martínez E, Hernán M, Martínez de Salazar P and García de Albéniz X.

    Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers

    CLINICAL MICROBIOLOGY AND INFECTION . 29(1): 85-93. Nº de cites: 10

    [doi:10.1016/j.cmi.2022.07.006]

  • Soler-García a, Gamell A, Pérez-Porcuna T, Soriano-Arandes A, Begoña Santiago García, Tórtola T, Ruiz-Serrano MJ, Korta Murua JJ, Bustillo-Alonso M, Garrote-Llanos MI, Rodríguez-Molino P, Piqueras AI, Tagarro A, Manuel Monsonis Cabedo, Tebruegge M, Noguera-Julian A and QFT-Plus Study Group of the Spanish Pediatric TB Research Network.

    Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study

    Thorax . 77(12): 1193-1201. Nº de cites: 13

    [doi:10.1136/thoraxjnl-2021-217592]

  • Velasco E, Batllori-Tragant M, Manuel Monsonis Cabedo, Valls-Lafon A, Rios-Barnés M, Simó-Nebot S, Gamell Fullà A, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.

    Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age

    SCIENTIFIC REPORTS . 12(1): 19908-19908. Nº de cites: 3

    [doi:10.1038/s41598-022-24433-w]

  • Aguilera-Alonso, D, Solis-Garcia, G, Noguera-Julian A, Gonzalez-Martin, J, Cobena, AR, Baquero-Artigao, F, Rueda, CT, Rodriguez-Molino, P, Sanchez, IB, Vallmanya, T, Bernet-Sanchez, A, Domingo, LM, Rubio, A, Saavedra-Lozano, J, Ruiz-Serrano, MJ, Blazquez-Gamero, D, Lopez-Roa, P, Gomez-Pastrana, D, Prieto, MDL, Medina, EML, Gil-Brusola, A, Nalda, AM, Soriano-Arandes, A, Tortola, T, Falcon-Neyra, L, Galan, VG, Tebruegge, M and Santiago-Garcia, B.

    Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

    Thorax . 77(10): 1023-1029. Nº de cites: 9

    [doi:10.1136/thorax-2021-218378]

  • Torres-Fernandez D, Jiménez de Ory S, Fortuny-Guasch C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á and Prieto L.

    Integrase inhibitors in children and adolescents: clinical use and resistance

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(10): 2784-2792. Nº de cites: 4

    [doi:10.1093/jac/dkac259]